KDNY - Chinook Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Chinook Therapeutics's activity chart (see below) currently has 49 price targets and 41 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.7% with an average time for these price targets to be met of 458.64 days.

Most recent stock forecast was given by from WEDBUSH on 08-Aug-2023. First documented stock forecast 20-Apr-2015.

Best performing analysts who are covering KDNY - Chinook Therapeutics:

Joseph Pantginis Mark Breidenbach Emma Nealon Laura Chico Joseph Schwartz Joshua Schimmer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Jan-2021

$42

$1.61 (3.99%)

$36

3 years 2 months 4 days ago
(08-Aug-2023)

2/3 (66.67%)

$1.68 (4.17%)

460

Buy Since 05-Dec-2022

$30

$-10.39 (-25.72%)

$30

3 years 2 months 11 days ago
(01-Aug-2023)

1/2 (50%)

$-10.29 (-25.54%)

189

Hold Since 21-Jun-2023

$40

$-0.39 (-0.97%)

$40

3 years 3 months 21 days ago
(21-Jun-2023)

9/9 (100%)

$1.63 (4.25%)

329

Buy Since 02-Nov-2020

$40

$-0.39 (-0.97%)

$32

3 years 3 months 28 days ago
(14-Jun-2023)

2/2 (100%)

$2.37 (6.30%)

500

Buy Since 07-Oct-2020

$40

$-0.39 (-0.97%)

$44

3 years 3 months 29 days ago
(13-Jun-2023)

2/3 (66.67%)

$2.13 (5.62%)

516

Show more analysts

Please expand the browser size to see the chart

What is KDNY (Chinook Therapeutics) average time for price targets to be met?

On average it took 459 days for the stock forecasts to be reached, with an average price target met ratio of 76.7%.

Which analyst most recently updated their price target on KDNY (Chinook Therapeutics)?

Which analyst has the most public recommendations on KDNY (Chinook Therapeutics)?

has 0 price targets and 0 ratings on KDNY

Which analyst is the currently most bullish on KDNY (Chinook Therapeutics)?

Mark Breidenbach with the highest potential upside of $34.61

Which analyst is the currently most reserved on KDNY (Chinook Therapeutics)?

Mohit Bansal with the lowest potential downside of -$10.39
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?